- £746.72m
- £1.98bn
- £1.51bn
- 45
- 58
- 34
- 39
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.89 | ||
| PEG Ratio (f) | 0.64 | ||
| EPS Growth (f) | 30.58% | ||
| Dividend Yield (f) | 1.79% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1 | ||
| Price to Tang. Book | 2.4 | ||
| Price to Free Cashflow | 6.04 | ||
| Price to Sales | 0.49 | ||
| EV to EBITDA | 8.13 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.87% | ||
| Return on Equity | 3.41% | ||
| Operating Margin | 9.1% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 557.2 | 1,048.1 | 1,195 | 1,359 | 1,511.2 | 1,602.99 | 1,688.97 | 9.03% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +82.79 | +17.33 | +22.01 | +47.07 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Spire Healthcare Group plc is a United Kingdom-based independent healthcare company. The Company operates approximately 38 hospitals and over 50 clinics, medical centers and consulting rooms across England, Wales and Scotland. It provides diagnostics, inpatient, day case and outpatient care in areas including orthopedics, gynecology, cardiology, neurology, oncology and general surgery. It also operates a network of private general practitioners (GPs), delivers private, National Health Service (NHS) and corporate mental health, dermatological and musculoskeletal services, and provides occupational health services to over 800 corporate clients. The Company also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand. Its treatments include back surgery, breast enlargement, cataract removal surgery, gastric bypass surgery, hip replacement surgery, knee replacement, and Prostate surgery.
Directors
- Ian Cheshire NEC
- Justinian Ash CEO (56)
- Martin Angle NVC (70)
- Jitesh Sodha CFO (53)
- John Forrest COO (49)
- Gillian Fairfield GCN
- Shelley Thomas DHR
- Cathy Cale OTH
- Peter Corfield OTH (49)
- Alison Dickinson OTH
- Ronnie Van Der Merwe NED (57)
- Adele Anderson NID (54)
- Anthony Bourne NID
- Janet Husband NID (78)
- Jenny Kay NID
- Simon Rowlands NID (63)
- Clifford Shearman NID
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 12th, 2014
- Public Since
- July 18th, 2014
- No. of Shareholders
- 494
- No. of Employees
- 17,600
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
London Stock Exchange- Shares in Issue
- 402,759,599
- Address
- 3 Dorset Rise, LONDON, EC4Y 8EN
- Web
- https://www.spirehealthcare.com/
- Phone
- Contact
- Angus Prentice
- Auditors
- Ernst & Young LLP
Latest News for SPI
Upcoming Events for SPI
Spire Healthcare Group PLC Annual Shareholders Meeting
Spire Healthcare Group PLC Annual Shareholders Meeting
Dividend For SPI.L - 2.3000 GBX
Half Year 2025 Spire Healthcare Group PLC Earnings Release
Similar to SPI
Chill Brands
London Stock Exchange
CVS
London Stock Exchange
Hellenic Dynamics
London Stock Exchange
Integrated Diagnostics Holdings
London Stock Exchange
IQ-AI
London Stock Exchange
FAQ
As of Today at 23:23 UTC, shares in Spire Healthcare are trading at 185.40p. This share price information is delayed by 15 minutes.
Shares in Spire Healthcare last closed at 185.40p and the price had moved by -22.26% over the past 365 days. In terms of relative price strength the Spire Healthcare share price has underperformed the FTSE All Share Index by -25.32% over the past year.
The overall consensus recommendation for Spire Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Spire Healthcare dividend yield is 1.24% based on the trailing twelve month period.
Last year, Spire Healthcare paid a total dividend of £0.02, and it currently has a trailing dividend yield of 1.24%.Looking ahead, shares in Spire Healthcare are due to go ex-dividend on 2025-05-22 and the next dividend pay date is 2025-06-20.
Spire Healthcare are due to go ex-dividend on 2025-05-22 and the next dividend pay date is 2025-06-20. The historic dividend yield on Spire Healthcare shares is currently 1.24%.
To buy shares in Spire Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 185.40p, shares in Spire Healthcare had a market capitalisation of £746.72m.
Here are the trading details for Spire Healthcare:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: SPI
Based on an overall assessment of its quality, value and momentum Spire Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Spire Healthcare is 288.57p. That is 55.65% above the last closing price of 185.40p.
Analysts covering Spire Healthcare currently have a consensus Earnings Per Share (EPS) forecast of £0.11 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Spire Healthcare. Over the past six months, its share price has underperformed the FTSE All Share Index by -17.56%.
As of the last closing price of 185.40p, shares in Spire Healthcare were trading -17.47% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Spire Healthcare PE ratio based on its reported earnings over the past 12 months is 14.89. The shares last closed at 185.40p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Spire Healthcare's management team is headed by:
- Ian Cheshire - NEC
- Justinian Ash - CEO
- Martin Angle - NVC
- Jitesh Sodha - CFO
- John Forrest - COO
- Gillian Fairfield - GCN
- Shelley Thomas - DHR
- Cathy Cale - OTH
- Peter Corfield - OTH
- Alison Dickinson - OTH
- Ronnie Van Der Merwe - NED
- Adele Anderson - NID
- Anthony Bourne - NID
- Janet Husband - NID
- Jenny Kay - NID
- Simon Rowlands - NID
- Clifford Shearman - NID